Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.jvca.2024.06.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impella: A New Dawn or Another IABP?
J Cardiothorac Vasc Anesth
September 2024
Department of Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, Augusta, GA. Electronic address:
Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
Circ Res
February 2017
From the Cardiovascular Medicine, University of Louisville School of Medicine, KY (M.P.F., S.P., T.K., S.D., J.H.L., W.R.); Internal Medicine, Sparks Regional Medical Center, Fort Smith, AR (S.V.P.); Cardiology, University of Kansas Medical Center, Kansas City (B.D.); Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO (A.C.); and Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia (C.R.B.).
Rationale: Acute kidney injury (AKI) is common during high-risk percutaneous coronary intervention (PCI), particularly in those with severely reduced left ventricular ejection fraction. The impact of partial hemodynamic support with a microaxial percutaneous left ventricular assist device (pLVAD) on renal function after high-risk PCI remains unknown.
Objective: We tested the hypothesis that partial hemodynamic support with the Impella 2.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!